https://www.mangaloremirror.com/affini-t-therapeutics-presents-preclinical-data-from-its-oncogenic-driver-programs-targeting-kras-g12d-and-p53-r175h-at-the-american-association-for-cancer-research-aacr-annual-meeting-2024/